Electromed, Inc. reported record financial results for the fourth quarter and full fiscal year ended June 30, 2026. Full-year net revenue increased 15.3% to $73.8 million, with operating income rising 43.7% to a record $13.9 million and diluted earnings per share reaching $1.30 compared to $0.85 in the prior year. The company repurchased $3.9 million of common stock during the fiscal year and held $20.5 million in cash with no debt as of June 30, 2026. Additionally, President and CEO James L. Cunniff announced his intention to retire effective on or about April 2, 2027, prompting the Board to initiate a search for his successor. Electromed manufactures airway clearance therapy devices for patients with compromised pulmonary function.